01.06.2012
- Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...
28.05.2012
- Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...
25.05.2012
- Takeda Pharmaceutical, Japan's top drugmaker, is to buy Brazil's Multilab for up to 540 million Brazilian reals ($265 million) in a deal highlighting global drugmakers' appetite...
22.05.2012
- Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains made in the fight against the disease in the...
10.05.2012
- GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the...
28.04.2012
- French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
02.04.2012
- Teva Pharmaceutical Industries has launched U.S. sales of irbesartan and irbesartan-hydrochlorothiazide tablets, generic versions of Sanofi Aventis' high blood pressure treatments...
30.03.2012
- France's drugs market is set to shrink in 2012 for the first time, hit by government austerity measures to curb healthcare spending, according to a study published by...
